Cargando…
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
The blood–brain barrier (BBB) regulates the delivery of oxygen and important nutrients to the brain through active and passive transport and prevents neurotoxins from entering the brain. It also has a clearance function and removes carbon dioxide and toxic metabolites from the central nervous system...
Autores principales: | Wu, Ying-Chieh, Sonninen, Tuuli-Maria, Peltonen, Sanni, Koistinaho, Jari, Lehtonen, Šárka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307585/ https://www.ncbi.nlm.nih.gov/pubmed/34299328 http://dx.doi.org/10.3390/ijms22147710 |
Ejemplares similares
-
Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases
por: Sonninen, Tuuli-Maria, et al.
Publicado: (2020) -
Dysfunction of Cellular Proteostasis in Parkinson’s Disease
por: Lehtonen, Šárka, et al.
Publicado: (2019) -
Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling
por: Koivumäki, Jussi T., et al.
Publicado: (2018) -
Recent advances in human iPSC-derived models of the blood–brain barrier
por: Workman, Michael J., et al.
Publicado: (2020) -
The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model
por: Katt, Moriah E., et al.
Publicado: (2019)